Patient info

Cetraxal 2 mg / ml ear drops solution – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
Prescription only (POM)
Medicine strength:
2 mg / ml
Contains active substance:

Patient leaflet - Cetraxal 2 mg / ml ear drops solution

1. WHAT CETRAXAL IS AND WHAT IT IS USED FOR

Cetraxal 2mg/ml ear drops solution is a solution for auricular use (in the ear) that contains ciprofloxacin, the active substance which is an antibacterial agent belonging to the group of fluoroquinolones. Ciprofloxacin works by killing bacteria that cause infections. Cetraxal 2mg/ml ear drops solution is indicated for the treatment of acute external otitis of bacterial origin in adults and children older than 1 year where the eardrum is still intact (see section 2. What you need to know before you use Cetraxal).

2. WHAT YOU NEED TO KNOW BEFORE YOU USE CETRAXAL

Do not use Cetraxal:

  • if you are allergic (hypersensitive) to ciprofloxacin, to any member of the quinolone class of antimicrobial agents or any of the other ingredients of this medicine (listed in section 6).

Warnings and Precautions

  • Once treatment has begun, if you develop urticaria (hives), skin rash or any other allergic symptoms (e.g. sudden swelling of face, throat or eyelids, respiratory difficulty), you must stop treatment immediately and you should consult with your doctor. Serious hypersensitivity reactions may need immediate emergency treatment.
  • This preparation should only be applied to the ear. It should not be swallowed, injected or inhaled. It should not be used in the eye.
  • Tell the doctor if the symptoms do not improve within one week of starting treatment.
  • As with all antibiotics, sometimes additional infections may occur caused by organisms which are not affected by ciprofloxacin. In case of such infection appropriate treatment should be started by your doctor.
  • Cetraxal 2mg/ml ear drops solution should be used with caution in patients with known or suspected perforation, or where there is a risk of perforation of the tympanic membrane.

Other medicines and Cetraxal

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription. Their use in conjunction with other ear preparations is not recommended.

Pregnancy, breast-feeding and fertility

Cetraxal can be used during pregnancy and during breast-feeding.

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Driving and using machines

Cetraxal does not affect the ability to drive vehicles or operate dangerous machinery.

3. HOW TO USE CETRAXAL

Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

This medicine is intended to be administered into the ear. It should not be swallowed, injected or inhaled.

Dosage

The recommended dose is for children (age 1 year and older) and adults, the contents of 1 single ampoule should be instilled into the affected ear twice daily for seven days. Administration

Warm the solution, by holding the ampoule in the hand for several minutes, to avoid the dizziness that may result from the instillation of a cold solution into the ear canal. Lie with the affected ear upward and then instil the drops pulling several times on the auricle. Maintain the position for around 5 minutes, to facilitate penetration of the drops into the ear. When you stand up again, some drops can fall out. You can dry them with a non-sterile absorbent paper. Repeat, if necessary, for the opposite ear.

If the auditory canal is narrow, the medicine can be made to reach the eardrum by pulling the ear upwards.

It is of the most importance to follow this instruction to have a good efficacy of the drug in your ear. When you instil ear drops, maintaining your head vertically or moving your head too rapidly will cause you to lose a part of the drug because drops are going to run down on your face and do not go into the depth of the auditory canal.

Discard the single-dose container after the use. Do not keep it for subsequent use. PACKAGE LEAFLET: INFORMATION FOR THE USER

Cetraxal 2mg/ml

ear drops, solution single-dose container

Ciprofloxacin

If you use more Cetraxal than you should

Since this is a single-dose preparation, an accidental overdose is unlikely. In any case you should contact your doctor or pharmacist for advice.

If you forget to use Cetraxal

Do not use a double dose to make up for a missed one.

If you forget to apply your drops, apply the correct dose when you remember or if it is close to your next application then wait until this time.

If you stop using Cetraxal

It is very important to use these eardrops for as long as the doctor has instructed, even if the symptoms improve. Do not interrupt your treatment before time, as the infection could return. If you have any further questions on the use of this product, ask your doctor or pharmacist.

4. POSSIBLE SIDE EFFECTS

Like all medicines, this medicine can cause side effects, although not everybody gets them. Uncommon: may affect up to 1 in 100 people:

  • Ear pruritus (itching), ringing in the ears
  • Headache
  • Dizziness
  • Local skin reactions or irritation (Dermatitis)
  • Pain in the application site

Very rare: may affect up to 1 in 10,000 people:

  • Rash
  • Blistering and tissue break down (Toxic epidermolysis)
  • Redness and scaling of the skin (Exfoliative dermatitis)
  • Serious allergic reaction with fever, red patches, joint pain and/or eye problems (Stevens-Johnson syndrome)
  • Skin allergy with development of itchiness and wheals (Urticaria)

If you consider that any of the side effects you suffer are serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme (website: www.mhra.gov.uk/yellowcard). By reporting side effects, you can help provide more information on the safety of this medicine.

5. HOW TO STORE CETRAXAL

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the package. The expiry date refers to the last day of that month.

Store below 30°C in the original package, in order to protect from light.

The ampoule contents should be used immediately after opening the single dose ampoule. Any unused contents should be discarded.

Once the pouch is opened, use within 8 days.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to dispose of packaging and medicines no longer required. These measures will help protect the environment.

6. CONTENTS OF THE PACK AND OTHER INFORMATION

What Cetraxal contains

  • The active substance is ciprofloxacin as hydrochloride.

    1ml solution contains 2mg of ciprofloxacin as hydrochloride. Each ampoule delivers 0.25ml of solution that contains 0.58mg of ciprofloxacin hydrochloride corresponding to 0.50mg of ciprofloxacin.

  • The other ingredients are povidone-K-90-F (E1201), glycerol (E422), purified water and sodium hydroxide (E524) and/or lactic acid (E270) for pH-adjustment.

What Cetraxal looks like and contents of the pack

Cetraxal is a clear ear drops solution contained in ampoules. The ampoules are packed in an aluminium foil overwrap pouch for protection. Each pack contains 15 ampoules.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder

Aspire Pharma Ltd

Unit 4, Rotherbrook Court

Bedford Rd, Petersfield

Hampshire, GU32 3QG

United Kingdom

Manufacturer

Laboratorios SALVAT, S.A.

C/ Gall, 30-36

08950 Esplugues de Llobregat

Barcelona

Spain

This leaflet was last revised in 10/2017.

1010385-P2.3

PL/PA no:

Type: Leaflet

Reason for request: COO-minor amends Version no: 2.3

Date of revision: 4.10.17

Colours: As swatch(es)

BAC ref: U173

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 35533/0130

Last revision stated in the text: 4 October 2017 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Cetraxal 2 mg / ml ear drops solution

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Ciprofloxacin
Strength 2 mg / ml
Pharmaceutical form Ear drops
Clear, sterile, preservative-free aqueous solution.
How is it taken Auricular
Excipients Povidone-K-90-F (E1201), Glycerol (E422), Purified water, Sodium hydroxide (E524) and lactic acid (E270) (for pH-adjustment).
Pack sizes 15 unit dose
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 2 years.
The ampoule contents should be used immediately after opening the single dose ampoule. Any unused contents should be discarded.
Shelf-life after first opening of the pouch: 8 days.
Storage Store below 30°C. Store in the original packaging in order to protect from light.
Drug group (ATC) S02AA15 Sensory organs. Otologicals. Antiinfectives
  1. S Sensory organ drugs
    1. S03 Ophthalmological and otological preparations
      1. S03A Antiinfectives, ophthalmologic and otologic
        1. S03AA Antiinfectives
          1. S03AA07 ciprofloxacin
Marketing authorisation PL 35533/0130 (first authorised 30 September 2015)
Marketing authorisation holder Aspire Pharma Ltd
Codes GTIN 5060209731827 · BNF 12010100

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.3.0 of 26 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.